Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,643 | 44 | 75.4% |
| Food and Beverage | $13,083 | 769 | 15.7% |
| Consulting Fee | $4,306 | 5 | 5.2% |
| Travel and Lodging | $1,744 | 5 | 2.1% |
| Honoraria | $1,200 | 1 | 1.4% |
| Education | $127.14 | 11 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $52,691 | 99 | $0 (2023) |
| Lilly USA, LLC | $14,890 | 110 | $0 (2023) |
| Shire North American Group Inc | $3,781 | 9 | $0 (2019) |
| Novo Nordisk Inc | $2,001 | 150 | $0 (2023) |
| Insulet Corporation | $1,305 | 61 | $0 (2022) |
| Horizon Therapeutics plc | $1,280 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $822.98 | 65 | $0 (2021) |
| Medtronic MiniMed, Inc. | $707.38 | 8 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $565.50 | 34 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $549.69 | 37 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $201.42 | 2 | Dexcom, Inc. ($121.40) |
| 2023 | $2,762 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,823) |
| 2022 | $7,784 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,162) |
| 2021 | $5,161 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,121) |
| 2020 | $8,311 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,843) |
| 2019 | $14,098 | 213 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,072) |
| 2018 | $16,524 | 210 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12,986) |
| 2017 | $28,262 | 232 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,684) |
All Payment Transactions
835 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $80.02 | General |
| Category: Automated insulin delivery system | ||||||
| 05/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $121.40 | General |
| Category: Endocrinology | ||||||
| 12/14/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $19.68 | General |
| Category: NEPHROLOGY | ||||||
| 05/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: DIABETES | ||||||
| 05/02/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Diabetes | ||||||
| 04/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: DIABETES | ||||||
| 04/04/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Diabetes | ||||||
| 03/30/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Bone Health | ||||||
| 03/23/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Endocrinology | ||||||
| 03/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes Care | ||||||
| 02/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes | ||||||
| 02/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Diabetes | ||||||
| 02/03/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $16.64 | General |
| Category: NEPHROLOGY | ||||||
| 01/19/2023 | Ipsen Biopharmaceuticals, Inc | Somatuline Depot (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oncology/Endocrinology | ||||||
| 01/11/2023 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Genetic Disease | ||||||
| 12/14/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes Care | ||||||
| 12/01/2022 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Oncology/Endocrinology | ||||||
| 11/30/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes Care | ||||||
| 11/22/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Bone Health | ||||||
| 11/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 178 | 178 | $34,011 | $5,053 |
| 2022 | 5 | 791 | 958 | $188,556 | $40,971 |
| 2021 | 10 | 956 | 1,243 | $218,488 | $60,591 |
| 2020 | 12 | 1,148 | 5,550 | $617,482 | $153,898 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 82 | $24,372 | $3,776 | 15.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 67 | 67 | $5,561 | $718.21 | 12.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $3,000 | $431.35 | 14.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 14 | 14 | $1,078 | $127.54 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 308 | 443 | $131,210 | $28,920 | 22.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 360 | 389 | $32,343 | $7,083 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 75 | $15,213 | $3,146 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 16 | $7,130 | $1,492 | 20.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 35 | 35 | $2,660 | $330.52 | 12.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 295 | 539 | $128,827 | $37,528 | 29.1% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 413 | 442 | $37,494 | $8,685 | 23.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 54 | $16,656 | $5,716 | 34.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 92 | $14,372 | $4,062 | 28.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $5,335 | $1,610 | 30.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,680 | $1,294 | 27.6% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 12 | 13 | $2,987 | $792.08 | 26.5% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 45 | 45 | $3,373 | $433.80 | 12.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 12 | $4,236 | $337.58 | 8.0% |
| 72020 | X-ray of spine, 1 view | Office | 2021 | 22 | 22 | $528.00 | $132.72 | 25.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 47 | 4,080 | $199,044 | $63,542 | 31.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 290 | 549 | $187,797 | $38,627 | 20.6% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 402 | 437 | $138,330 | $32,444 | 23.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 124 | 140 | $36,860 | $6,263 | 17.0% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2020 | 25 | 30 | $13,620 | $3,336 | 24.5% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 85 | 104 | $14,232 | $2,769 | 19.5% |
About Dr. Jay Watsky, M.D
Dr. Jay Watsky, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972500247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Watsky, M.D has received a total of $83,103 in payments from pharmaceutical and medical device companies, with $201.42 received in 2024. These payments were reported across 835 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,643).
As a Medicare-enrolled provider, Watsky has provided services to 3,073 Medicare beneficiaries, totaling 7,929 services with total Medicare billing of $260,513. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Albany, NY
- Active Since 07/01/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1972500247
Products in Payments
- JARDIANCE (Drug) $66,818
- NATPARA (Drug) $3,769
- Omnipod (Device) $1,305
- TEPEZZA (Drug) $1,268
- Ozempic (Drug) $927.70
- FARXIGA (Drug) $825.62
- Minimed 670G System (Device) $612.13
- INVOKANA (Drug) $489.22
- Victoza (Drug) $460.04
- Korlym (Drug) $387.99
- Tymlos (Biological) $362.14
- HUMULIN (Drug) $315.27
- SOMATULINE DEPOT (Drug) $261.61
- Repatha (Biological) $259.93
- SOLIQUA (Drug) $241.33
- t-slim insulin pump (Device) $233.02
- Synthroid (Drug) $233.01
- Saxenda (Drug) $230.13
- Minimed 770G System (Device) $221.07
- Somatuline Depot (Drug) $159.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Albany
Dr. Robert Busch, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4.1M
Dr. Gregg Gerety, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $665,599
Dr. Mark Fruiterman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $37,168
Dr. Michael Walker, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,934
Dr. Gary Bakst, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,831
Dr. Samer Eldeiry, M.d., Ph.d, M.D., PH.D
Endocrinology, Diabetes & Metabolism — Payments: $9,611